Table 3.
Multivariable models of correlates of migraine
| Bivariate | Multivariable | Multivariable | Multivariable | |
|---|---|---|---|---|
| r(p)/OR (95% CI) | BD/HC, β(p)a | BD only, β(p)b | BD men, β(p)c | |
| BD | N/A | 6.0 (3.0–12.2) | N/A | N/A |
| Female | 3.5 (2.1–5.8) | 3.9 (2.3–6.8) | 3.0 (1.6–5.6) | --- |
| BMI | .11 (0.05) | 1.04 (1.0–1.1) | b | c |
| Age | −.02 (.70) | --- | --- | --- |
| BD age at onset | −.05 (.27) | --- | --- | --- |
| BPII | 2.1 (1.2–3.6) | --- | b | --- |
| BPII-men | 4.2 (1.4–12.4) | --- | --- | 9.9 (2.3–41.9) |
| Rapid Cycling | 1.5 (0.99–2.4) | --- | 1.7 (0.99–2.9) | c |
| Rapid Cycling, men | 3.5 (1.4–8.8) | --- | --- | --- |
| Mixed symptoms | 2.0 (1.3–3.0) | --- | b | 3.5 (1.0–11.9) |
| Mixed episodes | 1.6 (0.97–2.5) | --- | --- | --- |
| Psychosis | 0.75 (0.49–1.2) | --- | --- | --- |
| Suicide attempt | 1.3 (0.83–1.9) | --- | --- | --- |
| Anxiety disorder | 1.2 (0.79–1.9) | --- | --- | --- |
| Drug use disorder | 1.3 (0.77–2.2) | --- | --- | --- |
| Alcohol use disorder | 1.1 (0.69–1.6) | --- | --- | --- |
a
controlled for age
b
controlled for serotonin norepinephrine reuptake inhibitor (SNRI) use; body mass index (BMI), BPII, and mixed symptoms eliminated from model by backward selection. “---” indicates variables that were not included in the model.
c
controlled for SNRI use; BMI, rapid cycling eliminated from model by backward selection. “---” indicates variables that were not included in the model.